Melanoma patients carry a high risk of developing brain metastases, and improvements in survival are still measured in weeks or months. Durable disease control within the brain is impeded by poor drug penetrat…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...